AI Science Tracker

RoseTTAFold

3 discoveries name this family, 2021 to 2024

Where RoseTTAFold appears in the catalog

Why linked?

These associations match family names in discovery titles and technology text. They are not verified model-version assignments or causal attribution. Missing links do not establish absence of use. A record may link to multiple families.

Represented fields

biology · 3 linked records

Test contexts

Test context unspecified in annotation · 1 linked records
direct test · 1 linked records
retrospective or benchmark · 1 linked records

Annotation coverage

Evidence annotation present · 3 linked records

Examples

Up to three linked records, newest publication date first, then stable ID. This selection is not a ranking.

Discoveries

Deep learning identifies previously unreported protein interactions in human bacterial pathogens

A RoseTTAFold2-Lite pipeline combined residue coevolution, deep-learning complex prediction and AlphaFold modelling to screen protein pairs across 19 human bacterial pathogens. In a validation set selected using the deep-learning pipeline, co-immunoprecipitation detected four of six predicted interactions. Three pairs lacked prior direct interaction evidence: E. coli UbiE–YcaR, P. aeruginosa PA4105–PA4106, and P. aeruginosa WbpG–HisF2. The PA4105–PA4106 structural similarity to proteins in 3-thiaglutamate biosynthesis and the WbpG–HisF2 result provide functional hypotheses, not established native-pathogen mechanisms.

Technology: RoseTTAFold2-Lite integrated with direct coupling analysis and AlphaFold complex modelling

Family AlphaFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: In a validation set selected using the deep-learning pipeline, co-immunoprecipitation detected four of six predicted interactions.
  • Still unknown: The positive interaction evidence comes from heterologous co-immunoprecipitation/pull-down assays, with two independent experiments per positive pair, rather than native-pathogen systems. The validation subset was small (four positives among six AI-selected candidates); most of the thousands of predicted interactions remain untested, and false positives and false negatives are expected. Proposed roles for PA4105–PA4106 and UbiE–YcaR remain hypotheses; this paper does not establish their physiological function or a therapeutic target.
  • AI role: RoseTTAFold2-Lite used residue–residue coevolution and predicted complex structures to rank candidate protein pairs in a proteome-wide screen. The authors selected six pairs from the final deep-learning pipeline for co-immunoprecipitation tests; four yielded positive interaction signals. Three were described as lacking previously reported direct interaction evidence, including UbiE–YcaR, PA4105–PA4106 and WbpG–HisF2. The models enabled the experimental target selection; they did not themselves establish physical interactions.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11445079/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 52 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

ColabFold: free protein folding with AlphaFold2 or RoseTTAFold

ColabFold pairs AlphaFold2 or RoseTTAFold with fast MMseqs2 homology search, running free on Google Colab. Beyond benchmark comparisons, the paper reports predicting structures for 1,762 Methanocaldococcus jannaschii proteins in 48 hours on one GPU and using predicted complexes to help determine the 120 MDa human nuclear-pore structure with cryo-electron microscopy. The proteome structures are computational predictions, not experimentally validated structures. The nuclear-pore application overlaps the separate nuclear-pore entry; this is a methodological contribution, not an additional independent biological finding.

Technology: ColabFold (AlphaFold2, RoseTTAFold, MMseqs2)

Family AlphaFold: profile · models page

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Throughput was measured (close to 1,000 structures per day on one GPU) and predicted complexes were used alongside cryo-EM to help determine the human nuclear-pore structure.
  • Still unknown: Not reported in the abstract read.
  • AI role: AlphaFold2 or RoseTTAFold, paired with MMseqs2 homology search, run free on Google Colaboratory.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41592-022-01488-1&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 9430 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

RoseTTAFold: accessible prediction of protein structures

A three-track neural network (sequence, residue interactions, and 3D structure) computes a structure in about ten minutes on a single gaming computer. Baker’s group predicted hundreds of new structures, including little-known proteins in the human genome. The web server received over 4,500 requests in the previous month. The page does not state limitations.

Technology: RoseTTAFold

Family RoseTTAFold: profile · models page

Publication: Peer-reviewed paper · Test context: Test context unspecified in annotation. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: not reported
  • Tested: The page describes the tool's speed and hundreds of new structures but does not describe how predictions were checked.
  • Still unknown: Not reported.
  • AI role: Three-track neural network predicted protein structures.

Evidence sources: https://www.ipd.uw.edu/2021/07/rosettafold-accurate-protein-structure-prediction-accessible-to-all/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A10.1126/science.abj8754&resultType=core&format=json

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 5653 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 1/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.

1 model release

Epoch AI data (CC BY 4.0), newest first. A discovery is attributed to a model family, not to a specific release.

DateModelAccess
RoseTTAFold All-Atom (RFAA) Open weights (unrestricted)